4//SEC Filing
Sirard Cynthia 4
Accession 0001104659-24-008419
CIK 0001509745other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 8:39 PM ET
Size
7.8 KB
Accession
0001104659-24-008419
Insider Transaction Report
Form 4
Sirard Cynthia
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-26+5,000→ 5,000 total - Exercise/Conversion
Restricted Stock Units
2024-01-26−5,000→ 0 total→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F2]The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.
- [F3]On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001808408
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 8:39 PM ET
- Size
- 7.8 KB